ESC 365 - Safety and efficacy of neladenoson bialanate in patients with chronic heart failure and reduced ejection fraction.

ESC Premium Access

Safety and efficacy of neladenoson bialanate in patients with chronic heart failure and reduced ejection fraction.

Session: Late Breaking Science in Heart Failure

Topic: Chronic Heart Failure, Other

Speaker: Professor A. Voors (Groningen, NL)

Event: ESC Congress 2018

Congress Presentation

Add to my library

About the speaker

Professor Adriaan Voors

University Medical Centre Groningen, Groningen (Netherlands (The))

77 presentations

1 follower

10 more presentations in this session

Panel discussants.

REDUCE LAP-HF I - Transcatheter InterAtrial Shunt Device for Heart Failure with Preserved Ejection Fraction (REDUCE LAP-HF I): 1-year Results from the Phase 2

Speaker: Doctor T. Feldman (Evanston, US)

Panel discussion.

PROMIS-HFpEF - Microvascular dysfunction in heart failure with preserved ejection fraction (HFpEF): Evidence from the prospective multicenter PRevalence Of Microvascular dySfunction in HFpEF

Speaker: Professor C. Lam (Singapore, SG)

Panel discussion.

Access the full session

Late Breaking Science in Heart Failure

Speakers: Professor A. Voors, Doctor T. Feldman, Professor C. Lam

About the event

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources